02 Nov 2023
M42: Abu Dhabi's global health-tech innovator takes on sustainability challenges at COP28

Pharmaceutical manufacturing hub and bio-therapeutics projects in collaboration with Tier 1 pharma giants.

  • Robust manufacturing

    Access to robust manufacturing infrastructure to support national vision

  • Uniquely diverse datasets and capabilities

    Access to uniquely diverse datasets and capabilities through inhouse clinical research arm

  • Co-owning research with pharma entities

    Co-owning research with pharma entities - initiating genomics R&D research

  • Building national disease registry

    Building national disease registry in the UAE